The Swiss are \u201cvery angry, understandably, and [the pharmaceutical] industry are angry, because the U.K. has turned around and said: \u2018No, we don\u2019t really want to do this,\u2019\u201d said one of the people briefed on the talks. They were granted anonymity to discuss private negotiations.<\/p>\n
\u201cThe U.K. and Switzerland have always been partners internationally on promoting innovation and strong IP rights. For the U.K. to turn around to Switzerland and say: \u2018Even though this is law already, we\u2019re not willing to write it into the FTA,\u2019 is like abandoning your best buddy.\u201d\u00a0<\/p>\n
By refusing to include IP protections in the deal, \u201cit reduces the incentive to put a medicine on the U.K. market,\u201d they explained. \u201cBecause, if you’ve got less protection for a period of time, then you’re not able to recoup as much of your money invested in the development of the medicine.”<\/p>\n
EU overhaul<\/p>\n
The EU is currently overhauling its pharmaceutical laws, after the Council of the EU and European Parliament reached a deal on<\/a> an<\/a> \u201cEU pharma package\u201d<\/a> to update pharma’s monopoly rights for new drugs, streamline regulatory processes and oblige companies to launch in EU markets if countries request it.<\/p>\n Brussels is also considering a new bill that will give homegrown biotech drugs an extra year of patent protection through an SPC \u2014 a measure which will soon begin\u00a0 legislative talks in the European Parliament and among national experts.<\/p>\n \u201cThe EU is changing its IP rights,\u201d noted the person familiar with the talks. \u201cSo the suspicion is that, if the EU reduces their protections, then the U.K. might go: \u2018Well, we want to be able to reduce our protections as well to compete for the generics industry.\u2019\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"The Swiss are \u201cvery angry, understandably, and [the pharmaceutical] industry are angry, because the U.K. has turned around…\n","protected":false},"author":2,"featured_media":38628,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[4],"tags":[22497,2370,22498,22499,2115,18,3824,1101,22500,250,1831,231,22501,4070,3708,2536,19237,12081,41,17,112,497,10062,1106,74],"class_list":["post-38627","post","type-post","status-publish","format-standard","has-post-thumbnail","category-switzerland","tag-biotech-drugs","tag-companies","tag-department-for-business-and-trade","tag-department-of-health","tag-development","tag-donald-trump","tag-industry","tag-innovation","tag-intellectual-property","tag-investment","tag-life-sciences","tag-markets","tag-medicines","tag-negotiations","tag-patents","tag-pharma","tag-rights","tag-services","tag-swiss","tag-switzerland","tag-tariffs","tag-trade","tag-trade-agreements","tag-united-kingdom","tag-united-states"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116290412039078247","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/38627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=38627"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/38627\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/38628"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=38627"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=38627"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=38627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}